Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U P Strauss

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biophysical Chemistry|June 1, 1980
Thermodynamics of hydrophobic polyacidsP J Martin, U P Strauss
Advances in Experimental Medicine and Biology|January 1, 1991
Volume effects of starch-water interactionsU P Strauss, R J Porcja, S Y Chen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settingsJ Beck, G Procopio, E Bajetta, et al.
British Journal of Cancer|July 14, 2011
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studiesT Eisen, R Marais, A Affolter, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biophysical Chemistry|June 1, 1980
Thermodynamics of hydrophobic polyacidsP J Martin, U P Strauss
Advances in Experimental Medicine and Biology|January 1, 1991
Volume effects of starch-water interactionsU P Strauss, R J Porcja, S Y Chen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settingsJ Beck, G Procopio, E Bajetta, et al.
British Journal of Cancer|July 14, 2011
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studiesT Eisen, R Marais, A Affolter, et al.
Pageof 1